Top Markets
#1 0G 0G +42.31%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.73%
#3 Useless Coin Useless Coin +35.33%
#4 SAFEcoin SAFEcoin +30.67%
#5 StonkBroker StonkBroker +27.91%
#6 Arbitrum Arbitrum +26.80%
#7 Notcoin Notcoin +19.30%
#8 Full Moon Full Moon +18.20%
#9 Zora Zora +17.22%
#10 rsERG rsERG +15.54%
Coin of the day
0G 0G
設定
言語
日本
通貨
USD
テーマ
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
株式のランク #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
株価
$3.83
時価総額
$464.45M
変化（1日）
-1.63%
変化（1年）
17.17%
国
TW
取引 Gongwin Biopharm Holdings Co., Ltd. (6617)

カテゴリー

Healthcare
Gongwin Biopharm Holdings Co., Ltd.（6617）のP/B比率
2026 時点のP/B比率 TTM: 0
Gongwin Biopharm Holdings Co., Ltd. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Gongwin Biopharm Holdings Co., Ltd. の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 -24.3279 -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 -19.2508 -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 5.5898 -
AU